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Background: LMNA cardiomyopathy, a common cause of genetic dilated cardiomyopathy (DCM), has been reported to present with ECG 
abnormalities, CSD and/or arrhythmias prior to the onset of DCM. Greater knowledge of the time interval between the onset of CSD and its 
progression to DCM would aid in the timing of clinical surveillance and intervention with drugs or devices. This may also enable more thoughtful 
research study design.
Methods: We evaluated 103 family members from 16 pedigrees, all previously identified with DCM attributable to LMNA mutations, for the ages of 
onset of ECG abnormalities, CSD or arrhythmia, and the ages of onset of left ventricular enlargement (LVE), systolic dysfunction or both.
Results: Of the 103 subjects, 64 carried their family LMNA mutation. ECG abnormalities were observed in 51 of the 64 (79%), with a median age 
of onset of 41 years (range 18-76); sinoatrial disease was observed in 35, and in 15 was the initial ECG abnormality; only one subject had DCM 
without any ECG abnormalities. Of 16 subjects identified with only ECG abnormalities who eventually developed ventricular dysfunction, the median 
ages of onset were 41 and 48 years, respectively.
Conclusion: In almost all cases ECG abnormalities preceded DCM with a median difference of seven years, information useful to inform clinical 
care and to assist in planning clinical studies.
